Moeka Mukae , Je-Won Ko , Hyo-Jung Kwun , In-Jeoung Baek , Sang R. Lee , Eui-Ju Hong
{"title":"黄体酮受体膜组分1通过与转化生长因子β受体相互作用加速肝纤维化。","authors":"Moeka Mukae , Je-Won Ko , Hyo-Jung Kwun , In-Jeoung Baek , Sang R. Lee , Eui-Ju Hong","doi":"10.1016/j.lfs.2025.124000","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Transforming growth factor-beta (TGF-β) is a central driver of hepatic stellate cell (HSC) activation via SMAD signaling, ultimately contributing to liver fibrosis and cirrhosis. While progesterone receptor membrane component 1 (Pgrmc1), a non-canonical progesterone receptor, has been implicated in liver metabolism, its role in liver fibrosis remains poorly understood.</div></div><div><h3>Main methods</h3><div>To investigate the involvement of PGRMC1 in liver fibrosis, we analyzed public Gene Expression Omnibus (GEO) datasets from cirrhotic patients. A carbon tetrachloride (CCl₄)-induced liver fibrosis model was established in wild-type and Pgrmc1-knockout (KO) mice. Additionally, primary hepatocytes and Lx-2 cells were used to explore cell-type specific signaling pathways.</div></div><div><h3>Key findings</h3><div>Public dataset analysis revealed that higher PGRMC1 expression is associated with cirrhosis development and shorter survival in cirrhotic patients. In a CCl₄-induced model, Pgrmc1-KO mice exhibited significant resistance to liver fibrosis with suppression of TGF-β signaling. However, Pgrmc1-KO primary hepatocytes were prone to CCl₄-induced apoptosis. Instead, PGRMC1 knockdown significantly reduced TGF-β receptor (TGF-βR) protein levels and SMAD phosphorylation. Inhibition of TGF-βR1 abrogated the reduction in SMAD phosphorylation observed in PGRMC1-knockdown cells and co-immunoprecipitation assay revealed the interaction between PGRMC1 and TGF-βR.</div></div><div><h3>Significance</h3><div>Collectively, our findings demonstrate that PGRMC1 plays a crucial role in liver fibrosis progression by regulating TGF-βR, highlighting its potential as a promising therapeutic target for antibody-based treatment.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"381 ","pages":"Article 124000"},"PeriodicalIF":5.1000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Progesterone receptor membrane component 1 accelerates liver fibrosis by interacting with transforming growth factor β receptor\",\"authors\":\"Moeka Mukae , Je-Won Ko , Hyo-Jung Kwun , In-Jeoung Baek , Sang R. Lee , Eui-Ju Hong\",\"doi\":\"10.1016/j.lfs.2025.124000\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aims</h3><div>Transforming growth factor-beta (TGF-β) is a central driver of hepatic stellate cell (HSC) activation via SMAD signaling, ultimately contributing to liver fibrosis and cirrhosis. While progesterone receptor membrane component 1 (Pgrmc1), a non-canonical progesterone receptor, has been implicated in liver metabolism, its role in liver fibrosis remains poorly understood.</div></div><div><h3>Main methods</h3><div>To investigate the involvement of PGRMC1 in liver fibrosis, we analyzed public Gene Expression Omnibus (GEO) datasets from cirrhotic patients. A carbon tetrachloride (CCl₄)-induced liver fibrosis model was established in wild-type and Pgrmc1-knockout (KO) mice. Additionally, primary hepatocytes and Lx-2 cells were used to explore cell-type specific signaling pathways.</div></div><div><h3>Key findings</h3><div>Public dataset analysis revealed that higher PGRMC1 expression is associated with cirrhosis development and shorter survival in cirrhotic patients. In a CCl₄-induced model, Pgrmc1-KO mice exhibited significant resistance to liver fibrosis with suppression of TGF-β signaling. However, Pgrmc1-KO primary hepatocytes were prone to CCl₄-induced apoptosis. Instead, PGRMC1 knockdown significantly reduced TGF-β receptor (TGF-βR) protein levels and SMAD phosphorylation. Inhibition of TGF-βR1 abrogated the reduction in SMAD phosphorylation observed in PGRMC1-knockdown cells and co-immunoprecipitation assay revealed the interaction between PGRMC1 and TGF-βR.</div></div><div><h3>Significance</h3><div>Collectively, our findings demonstrate that PGRMC1 plays a crucial role in liver fibrosis progression by regulating TGF-βR, highlighting its potential as a promising therapeutic target for antibody-based treatment.</div></div>\",\"PeriodicalId\":18122,\"journal\":{\"name\":\"Life sciences\",\"volume\":\"381 \",\"pages\":\"Article 124000\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Life sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0024320525006368\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0024320525006368","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Progesterone receptor membrane component 1 accelerates liver fibrosis by interacting with transforming growth factor β receptor
Aims
Transforming growth factor-beta (TGF-β) is a central driver of hepatic stellate cell (HSC) activation via SMAD signaling, ultimately contributing to liver fibrosis and cirrhosis. While progesterone receptor membrane component 1 (Pgrmc1), a non-canonical progesterone receptor, has been implicated in liver metabolism, its role in liver fibrosis remains poorly understood.
Main methods
To investigate the involvement of PGRMC1 in liver fibrosis, we analyzed public Gene Expression Omnibus (GEO) datasets from cirrhotic patients. A carbon tetrachloride (CCl₄)-induced liver fibrosis model was established in wild-type and Pgrmc1-knockout (KO) mice. Additionally, primary hepatocytes and Lx-2 cells were used to explore cell-type specific signaling pathways.
Key findings
Public dataset analysis revealed that higher PGRMC1 expression is associated with cirrhosis development and shorter survival in cirrhotic patients. In a CCl₄-induced model, Pgrmc1-KO mice exhibited significant resistance to liver fibrosis with suppression of TGF-β signaling. However, Pgrmc1-KO primary hepatocytes were prone to CCl₄-induced apoptosis. Instead, PGRMC1 knockdown significantly reduced TGF-β receptor (TGF-βR) protein levels and SMAD phosphorylation. Inhibition of TGF-βR1 abrogated the reduction in SMAD phosphorylation observed in PGRMC1-knockdown cells and co-immunoprecipitation assay revealed the interaction between PGRMC1 and TGF-βR.
Significance
Collectively, our findings demonstrate that PGRMC1 plays a crucial role in liver fibrosis progression by regulating TGF-βR, highlighting its potential as a promising therapeutic target for antibody-based treatment.
期刊介绍:
Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed.
The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.